细胞衰老对癌症治疗的影响：这是真的吗？
The impact of cellular senescence in cancer therapy: is it true or not?
机构信息
Department of Pharmacology, School of Pharmacy, Soochow University, Suzhou, China.
出版信息
Acta Pharmacol Sin. 2011 Oct;32(10):1199-207. doi: 10.1038/aps.2011.108. Epub 2011 Sep 12.
Abstract
Cellular senescence is defined as the physiological program of terminal growth arrest, which can be triggered by various endogenous or exogenous stress signals. Cellular senescence can be induced in response to oncogenic activation and acts as a barrier to tumorigenesis. Moreover, tumor cells can undergo senescence when exposed to chemotherapeutic agents. In addition to suppressing tumorigenesis, senescent cells remain metabolically active and may contribute to tumor formation and to therapy resistance. In the current review, we discuss the molecular regulation of cellular senescence, the potential implications of senescence in human cancers, and the possibility of exploiting cellular senescence for the treatment of cancers.
摘要
细胞衰老被定义为一种终端生长停滞的生理程序，可被各种内源性或外源性应激信号触发。细胞衰老可响应致癌激活而被诱导，并作为肿瘤发生的障碍。此外，当肿瘤细胞暴露于化疗药物时，它们也可能会衰老。除了抑制肿瘤发生之外，衰老细胞仍然具有代谢活性，并可能有助于肿瘤形成和治疗耐药性。在当前的综述中，我们讨论了细胞衰老的分子调控、衰老在人类癌症中的潜在意义，以及利用细胞衰老治疗癌症的可能性。
相似文献
1
The impact of cellular senescence in cancer therapy: is it true or not?细胞衰老对癌症治疗的影响：这是真的吗？
Acta Pharmacol Sin. 2011 Oct;32(10):1199-207. doi: 10.1038/aps.2011.108. Epub 2011 Sep 12.
2
Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.二苯乙烯类化合物通过诱导细胞衰老和抑制端粒酶活性来抑制肿瘤生长。
Int J Mol Sci. 2019 Jun 2;20(11):2716. doi: 10.3390/ijms20112716.
3
Hallmarks of senescence in carcinogenesis and cancer therapy.衰老在致癌作用和癌症治疗中的特征。
Oncogene. 2004 Apr 12;23(16):2919-33. doi: 10.1038/sj.onc.1207518.
4
Exploiting tumor cell senescence in anticancer therapy.在抗癌治疗中利用肿瘤细胞衰老。
BMB Rep. 2014 Feb;47(2):51-9. doi: 10.5483/bmbrep.2014.47.2.005.
5
Cellular senescence in the development and treatment of cancer.细胞衰老在癌症的发生发展和治疗中的作用
Curr Pharm Des. 2010 Jan;16(1):79-100. doi: 10.2174/138161210789941874.
6
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.hTERT基因表达的去抑制促进了从癌基因诱导的细胞衰老中逃逸。
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E5024-33. doi: 10.1073/pnas.1602379113. Epub 2016 Aug 8.
7
Senescence; an endogenous anticancer mechanism.衰老；一种内源性抗癌机制。
Front Biosci (Landmark Ed). 2012 Jun 1;17(7):2616-43. doi: 10.2741/4074.
8
Potential Telomere-Related Pharmacological Targets.潜在的端粒相关药理学靶点。
Curr Top Med Chem. 2020;20(6):458-484. doi: 10.2174/1568026620666200109114339.
9
Cancer cell senescence: a new frontier in drug development.癌细胞衰老：药物开发的新前沿。
Drug Discov Today. 2012 Mar;17(5-6):269-76. doi: 10.1016/j.drudis.2012.01.019. Epub 2012 Jan 31.
10
[Mechanism of cell proliferation--cell cycle, oncogenes, and senescence].[细胞增殖机制——细胞周期、癌基因与衰老]
Yakugaku Zasshi. 2006 Nov;126(11):1087-115. doi: 10.1248/yakushi.126.1087.
引用本文的文献
1
Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications.人参皂苷 Rg3：抗癌机制及其潜在治疗应用的综述。
Curr Top Med Chem. 2024;24(10):869-884. doi: 10.2174/0115680266283661240226052054.
2
The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells.紫杉醇对吉非替尼耐药非小细胞肺癌细胞生长抑制作用的机制。
Cancer Genomics Proteomics. 2021 Sep-Oct;18(5):661-673. doi: 10.21873/cgp.20288.
3
The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1.E3 泛素连接酶 STUB1 通过促进核心生物钟调节剂 BMAL1 的泛素化和降解来减弱细胞衰老。
J Biol Chem. 2020 Apr 3;295(14):4696-4708. doi: 10.1074/jbc.RA119.011280. Epub 2020 Feb 10.
4
HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells.HER2靶向酪氨酸激酶抑制剂可导致乳腺癌细胞发生治疗诱导性衰老。
Cancers (Basel). 2019 Feb 8;11(2):197. doi: 10.3390/cancers11020197.
5
P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment.由于芪三酚处理，p53依赖的hTERT蛋白表达下调和端粒酶活性诱导肺癌细胞衰老。
Cell Death Dis. 2017 Aug 10;8(8):e2985. doi: 10.1038/cddis.2017.333.
6
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks.利用人工神经网络进行衰老靶向虚拟筛选鉴定一种选择性G1期苯并咪唑酮抑制剂。
Neoplasia. 2015 Sep;17(9):704-715. doi: 10.1016/j.neo.2015.08.009.
7
Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.微小RNA miR-433的过表达通过诱导卵巢癌细胞衰老促进对紫杉醇的耐药性。
Cancer Med. 2015 May;4(5):745-58. doi: 10.1002/cam4.409. Epub 2015 Feb 15.
8
Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.沉默胶质瘤细胞上的促红细胞生成素受体可通过衰老和有丝分裂灾难增强替莫唑胺和X射线的疗效。
Oncotarget. 2015 Feb 10;6(4):2101-19. doi: 10.18632/oncotarget.2937.
9
The p53-reactivating small molecule RITA induces senescence in head and neck cancer cells.p53 激活小分子 RITA 可诱导头颈部癌细胞衰老。
PLoS One. 2014 Aug 13;9(8):e104821. doi: 10.1371/journal.pone.0104821. eCollection 2014.
10
Friend or foe: the role of microRNA in chemotherapy resistance.敌友难辨：miRNA 在化疗耐药中的作用。
Acta Pharmacol Sin. 2013 Jul;34(7):870-9. doi: 10.1038/aps.2013.35. Epub 2013 Apr 29.
本文引用的文献
1
The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway.淋巴瘤相关的 NPM-ALK 癌基因引发了一个 p16INK4a/pRb 依赖性的肿瘤抑制通路。
Blood. 2011 Jun 16;117(24):6617-26. doi: 10.1182/blood-2010-08-301135. Epub 2011 Apr 25.
2
MicroRNA profiling of human gastric cancer.人类胃癌的微小RNA分析
Mol Med Rep. 2009 Nov-Dec;2(6):963-70. doi: 10.3892/mmr_00000199.
3
Trefoil factor 1 acts to suppress senescence induced by oncogene activation during the cellular transformation process.三叶因子 1 通过在细胞转化过程中抑制致癌基因激活诱导的衰老来发挥作用。
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6591-6. doi: 10.1073/pnas.1017269108. Epub 2011 Mar 30.
4
Pancreatic cancers require autophagy for tumor growth.胰腺癌的生长需要自噬作用。
Genes Dev. 2011 Apr 1;25(7):717-29. doi: 10.1101/gad.2016111. Epub 2011 Mar 15.
5
Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival.致癌性 Ras 诱导 Noxa 和 Beclin-1 的表达促进自噬性细胞死亡并限制集落形成能力的存活。
Mol Cell. 2011 Apr 8;42(1):23-35. doi: 10.1016/j.molcel.2011.02.009. Epub 2011 Feb 25.
6
Images in clinical medicine. Palmar-plantar rash with cytarabine therapy.临床医学影像。阿糖胞苷治疗引起的掌跖皮疹。
N Engl J Med. 2011 Jan 20;364(3):e5. doi: 10.1056/NEJMicm1006530.
7
Resistance to discodermolide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent.对微管稳定剂和衰老诱导剂 discodermolide 的耐药性依赖于 4E-BP1。
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):391-6. doi: 10.1073/pnas.1016962108. Epub 2010 Dec 20.
8
Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.p16INK4a 和 p21Waf1/Cip1 在体内细胞衰老和肿瘤抑制中的内在协同作用。
Cancer Res. 2010 Nov 15;70(22):9381-90. doi: 10.1158/0008-5472.CAN-10-0801. Epub 2010 Nov 9.
9
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.miR-380-5p 通过抑制 p53 来控制细胞存活，与 MYCN 扩增型神经母细胞瘤的不良预后相关。
Nat Med. 2010 Oct;16(10):1134-40. doi: 10.1038/nm.2227. Epub 2010 Sep 26.
10
The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence.miR-17-92 簇 microRNAs 通过抑制癌基因诱导的衰老赋予肿瘤发生能力。
Cancer Res. 2010 Nov 1;70(21):8547-57. doi: 10.1158/0008-5472.CAN-10-1938. Epub 2010 Sep 17.
Zotero 插件